How do I find out if I qualify for a recurrent astrocytoma, idh-mutant, grade 4 study in California?

Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.

Do I have to live in California to take part?

Not necessarily. These studies have a site in California, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.

Does it cost anything to join a recurrent astrocytoma, idh-mutant, grade 4 trial?

Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Clinical trials · California

Recurrent Astrocytoma, IDH-Mutant, Grade 4 clinical trials in California

We’re tracking 4 recruiting recurrent astrocytoma, idh-mutant, grade 4 studies with a site in California — including Phase 1 and Phase 3 studies, each written for real people, not researchers.

Recruiting studies in California

NCT07544992RecruitingPhase 1
CAR T Cells for Recurrent High-Grade Brain Tumors
This trial tests genetically engineered immune cells (CAR T cells) injected directly into the brain to treat recurring or worsening high-grade gliomas. The cells are designed to recognize and attack tumor cells that have specific markers (EGFR and IL13Rα2).
Duarte, CaliforniaAges 18 years+
NCT06815029RecruitingPhase 1
Modified immune cells for recurrent brain cancer
This trial tests a new treatment using your own immune cells that are genetically modified to find and attack brain tumor cells. It is for people with a type of brain cancer that has come back after standard therapy.
Duarte, CaliforniaAges 18 years+
NCT06860594RecruitingPhase 1
Triapine plus radiation for recurrent brain tumors
This trial tests whether adding an experimental drug called triapine to a second round of radiation therapy can help treat brain tumors that have come back after initial treatment. It may be a good option for people with recurrent glioblastoma or astrocytoma who meet safety criteria.
Duarte, CaliforniaAges 18 years+
NCT05303519RecruitingPhase 3
Safusidenib for IDH1-mutant glioma after main treatment
This Phase 3 trial tests safusidenib, a targeted medicine, to help stop or slow the return of certain brain tumors with an IDH1 mutation. It focuses on people after initial treatment (surgery and/or radiation and temozolomide), aiming to improve outcomes during maintenance therapy.
La Jolla, CaliforniaAges 18 years+

Recurrent Astrocytoma, IDH-Mutant, Grade 4 trials by city in California

Where these studies are running in California

Institutions with a site for the recruiting recurrent astrocytoma, idh-mutant, grade 4 studies listed above.

City of Hope Comprehensive Cancer Center · 3 studies
Hoag Memorial Hospital Presbyterian
Stanford University
UC Irvine Health
UC San Diego Moores Cancer Center
University of California
University of California Davis Comprehensive Cancer Center
University of California San Diego Health

What taking part in a recurrent astrocytoma, idh-mutant, grade 4 study involves

A screening visit first

Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.

Care at a nearby site

Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.

You stay in control

Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.

The team decides eligibility

Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.

Common questions

Are there recurrent astrocytoma, idh-mutant, grade 4 clinical trials in California?: Yes. We're currently tracking 4 recruiting recurrent astrocytoma, idh-mutant, grade 4 studies with a site in California, each rewritten in plain language so you can see what it's testing and who it's for.
How do I find out if I qualify for a recurrent astrocytoma, idh-mutant, grade 4 study in California?: Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
Do I have to live in California to take part?: Not necessarily. These studies have a site in California, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
Does it cost anything to join a recurrent astrocytoma, idh-mutant, grade 4 trial?: Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Not the right time?

New recurrent astrocytoma, idh-mutant, grade 4 studies open in California regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.

Get told when a study that fits you opens

Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.